Using case management to increase antiinflammatory medication use among a managed care population with asthma

Journal of Asthma

Volumn 39, Issue 1, 2002, Pages 55-63

  Delaronde, Steven ^a  

^a Health Management Programs   (United States)

Author keywords

Anti inflammatory agents; Asthma; Beta2 agonists; Case management; Inhaled corticosteroids

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NEDOCROMIL;

ADULT; AMBULATORY CARE; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE CONTROL; DISEASE EXACERBATION; FEMALE; HEALTH CARE MANAGEMENT; HEALTH CARE ORGANIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; PATIENT CARE; PHARMACY; PRESCRIPTION; STEROID THERAPY;

ADRENERGIC BETA-AGONISTS; ADULT; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; CASE MANAGEMENT; FEMALE; HUMANS; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; TELEPHONE;

EID: 0036186780     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-120000807     Document Type: Article

References (28)

1. Treatment patterns among adult patients with asthma: Factors associated with overuse of inhaled beta-agonists and underuse of inhaled corticosteroids
2. Clinical pharmacology of nedocromil sodium
3. Sodium cromoglycate (Intal) as an anti-inflammatory agent for the treatment of chronic asthma
4. Salmeterol xinofoate as maintenance therapy compared with albuterol in patients with asthma
5. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma
6. Leukotriene-receptor antagonists: Role in asthma management
7. Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: A randomized clinical trial
8. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma
9. Fluticasone alone or in combination with salmeterol vs. triamcinolone in asthma
10. Reduction of asthma exacerbations with zafirlukast in patients on inhaled corticosteroids
11. Effect of early vs. late intervention with inhaled corticosteroids in asthma
12. Low-dose inhaled corticosteroids and the prevention of death from asthma
13. Inhaled steroids and the risk of hospitalization for asthma
14. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma
15. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma
16. Disease management program for asthma: Baseline assessment of resource use
17. Asthma management: Evidence based studies and their implications for cost-efficacy
18. A controlled trial of two forms of self-management education for adults with asthma
19. Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices
20. Theophylline: Recent advances in the understanding of its mode of action and uses in clinical practice
21. The use of beta-agonists and the risk of death and near death from asthma
22. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma
23. First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma
24. One-year economic evaluation of intensive vs. Conventional patient education and supervision for self-management of new asthmatic patients
25. Inhaled corticosteroids for asthma therapy
26. A national estimate of the economic costs of asthma
27. Outcomes and cost benefits associated with the introduction of inhaled corticosteroid therapy in a medicaid population of asthmatic patients